Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: IMO, quarterly report due out Monday
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Theoretically, with what we know, that is what we expect. A question I had several months ago related to TPL and PTSC dividing up yhe remaining infringement pool and Leckrone being allowed to "commingle" with his subset and the other subset being strictly MMP. That is a possibility as we have no visibility into the latest agreement.
2 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply